BX
Botanix Pharmaceuticals Limited
BXPHF · OTC
$0.02 +0.00% (+$0.00)
1M -35.71%
Market Cap $68.1M
P/E Ratio -
Div. Yield -
ROE 95.70%
Bulios Fair Price
$0.03
66.7% upside
Trenutna cena
$0.018
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica BXPHF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
88 /100
Cheap P/S 1.98x
P/B 1.07x
P/E N/A
Growth
100 /100
Growing Rev. growth 109.05%
Book val. growth 40.34%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 172.20%
FCF margin 187.17%
Net margin 202.15%
Quality
4 /100
Poor ROIC 77.62%
Asset turnover 0.33x
ROE 95.70%
Debt
69 /100
Low Debt/Equity 0.23x
Int. coverage -24.43x
Current ratio 2.59x
Stability
26 /100
Unstable Beta 0.86x
Profitable years 0
Rev. volatility 273.32%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BXPHF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Howie McKibbon
Employees
11
Headquarters
Melbourne
Prihajajoči dogodki
03 MAR.
Earnings
Upcoming earnings report